Most of the proteomic studies reported on cellular models are exclusively conducted on Triple-negative (TN) BC (TNBC) tumor subtypes, any BC characterized by the lack of expression of estrogen and progesterone receptor, and of human epidermal growth factor receptor 2. The gene discussed is ERBB2; the disease is breast cancer.